Author Archives | Simplyjo
Simplyjo - who has written 81 posts on FavStocks.
I have done by Post Graduation in Tourism from College of Vocational Studies apart from a full time MBA degree in Finance.I have worked with several reputed companies including IBM, MakeMyTrip and Habitat World.
I love to read, write and travel.
Currently, I am a SAHM ,earning a living off the stock market and making a killing with forex trades. I am sharing my knowledge so as to help others learn and expand their horizon.
ARCA Submits New SPA (NASDAQ:ABIO)
ARCA Biopharma, Inc (NASDAQ:ABIO) has announced that they have submitted a study protocol for review under Food and Drug Administration’s Special Protocol Assessment (SPA) process for the design of a clinical trial to assess the safety and efficacy of Gencaro.
Continue reading...Xcorporeal Signs Purchase Agreement (OTC:XCRP)
23 December 2009
Xcorporeal Inc (OTC:XCRP) has announced that they have signed an asset purchase agreement with National Quality Care Inc (NQCI) and Fresenius USA, Inc to sell substantially all of the assets of the Seller to the Purchaser for an aggregate cash price of $8,000,000.
Continue reading...Arrowhead Raises New Funds (NASDAQ:ARWR)
23 December 2009
Comments Off
Arrowhead Research Corporation (NASDAQ:ARWR) has announced that they have raised approximately $3.2 million in gross proceeds from a private placement of approximately 6.0 million units.
Continue reading...ProtoKinetix Receives European Proposals (OTC:PKTX)
16 December 2009
Comments Off
ProtoKinetix Inc (OTC:PKTX) has announced that they have recently been approached by a European biopharma investment group with a series of proposals for development of commercial partnerships in the areas like pharmaceuticals and cosmetics.
Continue reading...Advaxis Collaborates with NCI (OTC:ADXS)
16 December 2009
Advaxis Inc (OTC:ADXS) has announced that they will be collaborating their Phase 2 trial with the Gynecologic Oncology Group which is a collaborative research of National Cancer Institute.
Continue reading...GTx Announces Reduction in Workforce (NASDAQ:GTXI)
15 December 2009
Comments Off
GTx, Inc (NASDAQ:GTXI) has announced that they will be reducing their workforce due to delay in the potential commercialization of toremifene 80 mg that reduces fractures in men with prostrate cancer on androgen deprivation therapy (ADT).
Continue reading...BioMimetic Ships Augment Bone Graft (NASDAQ:BMTI)
15 December 2009
Comments Off
BioMimetic Therapeutics Inc (NASDAQ:BMTI) has announced that they have shipped their first order of Augment Bone Graft to their Canadian distributor, Joint Solutions Alliance Corporation.
Continue reading...Fero Industries’ Growth Strategy (OTC:FROI)
10 December 2009
Comments Off
Fero Industries, Inc (OTC:FROI) has announced their growth strategy publicly where they have disclose about Fero Industries first acquisition target which is Pyro Pharmaceuticals.
Continue reading...Medifocus Begins OTC Trading (OTC:MDFZE)
10 December 2009
Comments Off
Medifocus, Inc (OTC:MDFZE) has announced that they have begun trading their common stock on the over the counter (OTC) pink sheets market from Dec. 7, 2009.
Continue reading...Neoprobe Submits Phase 3 Data to FDA (OTC:NEOP)
9 December 2009
Comments Off
Neoprobe Corporation (OTC:NEOP) has announced that they have completed their Phase 3 clinical trial of Lmyphoseek (NEO3-35) with positive results and that they have submitted the data to US Food and Drug Administration to discuss the results of the clinical trial as part of our continuing preparation of a New Drug Application (NDA), which they [...]
Continue reading...
23 December 2009
Comments Off